Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1986 Jan 1;233(1):295–297. doi: 10.1042/bj2330295

Trans-stimulation and trans-inhibition of uridine efflux from human erythrocytes by permeant nucleosides.

S M Jarvis
PMCID: PMC1153021  PMID: 3954730

Abstract

The ability of nucleoside permeants to accelerate the efflux of uridine from human erythrocytes has been compared. In contrast to uridine, 2-chloroadenosine acted as a trans-inhibitor of uridine efflux from fresh human erythrocytes, and adenosine had little effect. These results are consistent with the lower maximum velocity for influx of 2-chloroadenosine and adenosine as compared with uridine and demonstrate that trans acceleration experiments do not discriminate between transported and non-transported permeants for the human erythrocyte nucleoside carrier.

Full text

PDF
295

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cabantchik Z. I., Ginsburg H. Transport of uridine in human red blood cells. Demonstration of a simple carrier-mediated process. J Gen Physiol. 1977 Jan;69(1):75–96. doi: 10.1085/jgp.69.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cass C. E., Paterson A. R. Mediated transport of nucleosides in human erythrocytes. Accelerative exchange diffusion of uridine and thymidine and specificity toward pyrimidine nucleosides as permeants. J Biol Chem. 1972 May 25;247(10):3314–3320. [PubMed] [Google Scholar]
  3. Jarvis S. M., Chapman J. D., Ngan-Lee J., Rutledge K. A., Barr P. J., Paterson A. R. Azomycin riboside, a sugar homologue of misonidazole with favorable radiosensitizing properties. Cancer Res. 1982 Nov;42(11):4358–4363. [PubMed] [Google Scholar]
  4. Jarvis S. M., Hammond J. R., Paterson A. R., Clanachan A. S. Nucleoside transport in human erythrocytes. A simple carrier with directional symmetry in fresh cells, but with directional asymmetry in cells from outdated blood. Biochem J. 1983 Feb 15;210(2):457–461. doi: 10.1042/bj2100457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jarvis S. M., Martin B. W., Ng A. S. 2-Chloroadenosine, a permeant for the nucleoside transporter. Biochem Pharmacol. 1985 Sep 15;34(18):3237–3241. doi: 10.1016/0006-2952(85)90340-5. [DOI] [PubMed] [Google Scholar]
  6. Jarvis S. M., Young J. D. Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites. Biochem J. 1980 Aug 15;190(2):377–383. doi: 10.1042/bj1900377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Oliver J. M., Paterson A. R. Nucleoside transport. I. A mediated process in human erythrocytes. Can J Biochem. 1971 Feb;49(2):262–270. doi: 10.1139/o71-038. [DOI] [PubMed] [Google Scholar]
  8. Paterson A. R., Harley E. R., Cass C. E. Inward fluxes of adenosine in erythrocytes and cultured cells measured by a quenched-flow method. Biochem J. 1984 Dec 15;224(3):1001–1008. doi: 10.1042/bj2241001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Paterson A. R., Kolassa N., Cass C. E. Transport of nucleoside drugs in animal cells. Pharmacol Ther. 1981;12(3):515–536. doi: 10.1016/0163-7258(81)90096-6. [DOI] [PubMed] [Google Scholar]
  10. Turnheim K., Plank B., Kolassa N. Inhibition of adenosine uptake in human erythrocytes by adenosine-5'-carboxamides, xylosyladenine, dipyridamole, hexobendine, and p-nitrobenzylthioguanosine. Biochem Pharmacol. 1978;27(18):2191–2197. doi: 10.1016/0006-2952(78)90076-x. [DOI] [PubMed] [Google Scholar]
  11. Young J. D., Jarvis S. M. Nucleoside transport in animal cells. Biosci Rep. 1983 Apr;3(4):309–322. doi: 10.1007/BF01122895. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES